6-(4-fluorophenoxy)-3-{[(3S)-1-isopropylpiperidin-3-yl]methyl}-2-(2-methylphenyl)quinazolin-4(3H)-one

ID: ALA242564

PubChem CID: 23631112

Max Phase: Preclinical

Molecular Formula: C30H32FN3O2

Molecular Weight: 485.60

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccccc1-c1nc2ccc(Oc3ccc(F)cc3)cc2c(=O)n1C[C@H]1CCCN(C(C)C)C1

Standard InChI:  InChI=1S/C30H32FN3O2/c1-20(2)33-16-6-8-22(18-33)19-34-29(26-9-5-4-7-21(26)3)32-28-15-14-25(17-27(28)30(34)35)36-24-12-10-23(31)11-13-24/h4-5,7,9-15,17,20,22H,6,8,16,18-19H2,1-3H3/t22-/m0/s1

Standard InChI Key:  KYGGFRZALCCXKR-QFIPXVFZSA-N

Molfile:  

     RDKit          2D

 36 40  0  0  1  0  0  0  0  0999 V2000
    9.1762  -24.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8935  -25.0330    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8896  -23.3840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1726  -23.7973    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6054  -23.7960    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6016  -24.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3113  -25.0320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0254  -24.6232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0252  -23.7970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3149  -23.3877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8893  -22.5590    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4573  -23.3862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4557  -22.5612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1711  -22.1454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1715  -21.3240    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4580  -20.9090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7425  -21.3216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7404  -22.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8867  -20.9128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6004  -21.3267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8883  -20.0878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4626  -25.0326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7508  -24.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0377  -25.0336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0390  -25.8595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7593  -26.2703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4695  -25.8547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1869  -26.2620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7395  -23.3842    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.4542  -23.7963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4518  -24.6219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1656  -25.0340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8809  -24.6211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8778  -23.7918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1634  -23.3835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5961  -25.0323    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  8  9  1  0
 15 19  1  0
  3  4  1  0
 19 20  1  0
  9 10  2  0
 19 21  1  0
 10  5  1  0
  1 22  1  0
  1  2  2  0
 22 23  2  0
  3 11  2  0
 23 24  1  0
 24 25  2  0
  4 12  1  0
 25 26  1  0
  5  6  2  0
 26 27  2  0
 27 22  1  0
 13 12  1  1
 27 28  1  0
 13 14  1  0
  9 29  1  0
  1  4  1  0
 29 30  1  0
  6  7  1  0
 30 31  2  0
  2  6  1  0
 31 32  1  0
  7  8  2  0
 32 33  2  0
  5  3  1  0
 33 34  1  0
 13 18  1  0
 34 35  2  0
 35 30  1  0
 14 15  1  0
 33 36  1  0
M  END

Associated Targets(Human)

HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ghrelin receptor (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 485.60Molecular Weight (Monoisotopic): 485.2479AlogP: 6.42#Rotatable Bonds: 6
Polar Surface Area: 47.36Molecular Species: BASEHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.14CX LogP: 6.31CX LogD: 4.57
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.32Np Likeness Score: -1.32

References

1. Rudolph J, Esler WP, O'connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH..  (2007)  Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.,  50  (21): [PMID:17887659] [10.1021/jm070071+]
2. Rudolph J, Esler WP, O'connor S, Coish PD, Wickens PL, Brands M, Bierer DE, Bloomquist BT, Bondar G, Chen L, Chuang CY, Claus TH, Fathi Z, Fu W, Khire UR, Kristie JA, Liu XG, Lowe DB, McClure AC, Michels M, Ortiz AA, Ramsden PD, Schoenleber RW, Shelekhin TE, Vakalopoulos A, Tang W, Wang L, Yi L, Gardell SJ, Livingston JN, Sweet LJ, Bullock WH..  (2007)  Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity.,  50  (21): [PMID:17887659] [10.1021/jm070071+]

Source